MetaADEDB 2.0 @ LMMD
Ivermectin
(SPBDXSGPUHCETR-VHJJIYNUSA-N)
Structure
SMILES
CO[C@H]1C[C@H](O[C@H]2[C@@H](C)/C=C/C=C/3\CO[C@H]4[C@]3(O)[C@@H](C=C([C@H]4O)C)C(=O)OC3C[C@@H](C/C=C/2\C)O[C@]2(C3)CC[C@@H]([C@H](O2)C(CC)C)C)O[C@H]([C@@H]1OC1C[C@H](OC)[C@H]([C@@H](O1)C)O)C.CO[C@H]1C[C@@H](O[C@H]([C@@H]1OC1C[C@H](OC)[C@H]([C@@H](O1)C)O)C)O[C@H]1[C@@H](C)/C=C/C=C/2\CO[C@H]3[C@]2(O)[C@@H](C=C([C@H]3O)C)C(=O)OC2C[C@@H](C/C=C/1\C)O[C@]1(C2)CC[C@@H]([C@H](O1)C(C)C)C
Molecular Formula:
C95H146O28
Molecular Weight:
1736.160
Log P:
10.8127
Hydrogen Bond Acceptor:
28
Hydrogen Bond Donor:
6
TPSA:
340.12
CAS Number(s):
N/A
Synonym(s)
1.
Ivermectin
2.
Eqvalan
3.
Ivomec
4.
MK-933
5.
Mectizan
6.
Stromectol
7.
MK 933
8.
MK933
External Link(s)
MeSHD007559
PubChem Compound6435110
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AstheniaFAERS: 562US FAERS
2HeadacheFAERS: 537US FAERS
3Back PainFAERS: 222US FAERS
4VertigoFAERS: 219US FAERS
5ArthralgiaFAERS: 158US FAERS
6Urinary IncontinenceFAERS: 138US FAERS
7PruritusFAERS: 124
Canada Vigilance: 1
Canada Vigilance
US FAERS
8MyalgiaFAERS: 107US FAERS
9Depressed Level of ConsciousnessFAERS: 100
Canada Vigilance: 1
Canada Vigilance
US FAERS
10VomitingFAERS: 89
Canada Vigilance: 1
Canada Vigilance
US FAERS
11ChillsFAERS: 83US FAERS
12AgitationFAERS: 61US FAERS
13PainFAERS: 59US FAERS
14MalariaFAERS: 57US FAERS
15HypotensionFAERS: 51US FAERS
16Neck PainFAERS: 46US FAERS
17Abdominal PainFAERS: 44US FAERS
18AnorexiaFAERS: 43US FAERS
19No adverse eventFAERS: 42US FAERS
20Adverse eventFAERS: 41US FAERS
21Drug ineffectiveFAERS: 31US FAERS
22DisorientationFAERS: 30US FAERS
23Inappropriate schedule of drug administrationFAERS: 29US FAERS
24Product use in unapproved indicationFAERS: 28US FAERS
25AphasiaFAERS: 27US FAERS
26StuporFAERS: 27US FAERS
27FatigueFAERS: 25US FAERS
28Chest PainFAERS: 23US FAERS
29Musculoskeletal stiffnessFAERS: 23US FAERS
30Nuchal RigidityFAERS: 23US FAERS
31SomnolenceFAERS: 19US FAERS
32Urinary RetentionFAERS: 18US FAERS
33DehydrationFAERS: 17US FAERS
34AbasiaFAERS: 15US FAERS
35NauseaFAERS: 15US FAERS
36Accidental exposureFAERS: 13US FAERS
37IncoherentFAERS: 13US FAERS
38Feeling ColdFAERS: 12US FAERS
39SepsisFAERS: 12US FAERS
40Eye painFAERS: 10US FAERS
41FilariasisFAERS: 10US FAERS
42Mental status changesFAERS: 10US FAERS
43MutismFAERS: 10US FAERS
44ParesisFAERS: 10US FAERS
45StrongyloidiasisFAERS: 10US FAERS
46UrticariaFAERS: 10US FAERS
47nervous system disorderFAERS: 10US FAERS
48Product use issueFAERS: 9US FAERS
49DeliriumFAERS: 8US FAERS
50DizzinessFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
51Drug ineffective for unapproved indicationFAERS: 8US FAERS
52MeningitisFAERS: 8US FAERS
53Cerebral disorderFAERS: 7US FAERS
54DisabilityFAERS: 7US FAERS
55Drug administration errorFAERS: 7US FAERS
56Joint stiffnessFAERS: 7US FAERS
57MonoparesisFAERS: 7US FAERS
58ParaparesisFAERS: 7US FAERS
59PneumoniaFAERS: 7US FAERS
60TachycardiaFAERS: 7US FAERS
61White blood cell count decreasedFAERS: 7US FAERS
62AcarodermatitisFAERS: 6US FAERS
63Altered state of consciousnessFAERS: 6US FAERS
64AmnesiaFAERS: 6US FAERS
65Blood smear test abnormalFAERS: 6US FAERS
66ConstipationFAERS: 6US FAERS
67Drug exposure during pregnancyFAERS: 6US FAERS
68EosinophiliaFAERS: 6US FAERS
69HepatitisFAERS: 6US FAERS
70Ocular icterusFAERS: 6US FAERS
71OverdoseFAERS: 6US FAERS
72PalpitationsFAERS: 6US FAERS
73Toxic Epidermal NecrolysisFAERS: 6US FAERS
74Anal sphincter atonyFAERS: 5US FAERS
75Coma scaleFAERS: 5US FAERS
76Erythema MultiformeFAERS: 5US FAERS
77HemiplegiaFAERS: 5US FAERS
78MalaiseFAERS: 5US FAERS
79PallorFAERS: 5US FAERS
80PhotophobiaFAERS: 5US FAERS
81PoisoningFAERS: 5US FAERS
82Respiratory FailureFAERS: 5US FAERS
83TremorFAERS: 5US FAERS
84Vitreous floatersFAERS: 5US FAERS
85Weight decreasedFAERS: 5US FAERS
86AngioedemaFAERS: 4US FAERS
87AtaxiaFAERS: 4US FAERS
88BedriddenFAERS: 4US FAERS
89Diet refusalFAERS: 4US FAERS
90DiplegiaFAERS: 4US FAERS
91Drug effect incompleteFAERS: 4US FAERS
92Drug prescribing errorFAERS: 4US FAERS
93General physical health deteriorationFAERS: 4US FAERS
94Glasgow coma scale abnormalFAERS: 4US FAERS
95HepatomegalyFAERS: 4US FAERS
96HypersensitivityFAERS: 4US FAERS
97IncontinenceFAERS: 4US FAERS
98LethargyFAERS: 4US FAERS
99LymphadenopathyFAERS: 4US FAERS
100Muscle RigidityFAERS: 4US FAERS
101OnchocerciasisFAERS: 4US FAERS
102Alanine Aminotransferase IncreasedFAERS: 3US FAERS
103AphoniaFAERS: 3US FAERS
104AscitesFAERS: 3US FAERS
105Body fat disorderFAERS: 3US FAERS
106BradycardiaFAERS: 3US FAERS
107BradyphreniaFAERS: 3US FAERS
108Cerebrovascular accidentFAERS: 3US FAERS
109Coma scale abnormalFAERS: 3US FAERS
110DiscomfortFAERS: 3US FAERS
111Drug dose omissionFAERS: 3US FAERS
112DysarthriaFAERS: 3US FAERS
113General symptomFAERS: 3US FAERS
114Hypertensive EncephalopathyFAERS: 3US FAERS
115Inappropriate schedule of product administrationFAERS: 3US FAERS
116Limb discomfortFAERS: 3US FAERS
117Prescribed overdoseFAERS: 3US FAERS
118Pulmonary congestionFAERS: 3US FAERS
119RalesFAERS: 3US FAERS
120Respiratory arrestFAERS: 3US FAERS
121Respiratory tract congestionFAERS: 3US FAERS
122Septic ShockFAERS: 3US FAERS
123ShockFAERS: 3US FAERS
124SplenomegalyFAERS: 3US FAERS
125Transaminases increasedFAERS: 3US FAERS
126Visual disturbanceFAERS: 3US FAERS
127jaundiceFAERS: 3US FAERS
128Abdominal discomfortFAERS: 2US FAERS
129Abdominal tendernessFAERS: 2US FAERS
130Accidental overdoseFAERS: 2US FAERS
131Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
132Bladder sphincter atonyFAERS: 2US FAERS
133Blighted ovumFAERS: 2US FAERS
134Cluster HeadacheFAERS: 2US FAERS
135ColitisFAERS: 2US FAERS
136Diabetic KetoacidosisFAERS: 2US FAERS
137Disseminated Intravascular CoagulationFAERS: 2US FAERS
138Drug effective for unapproved indicationFAERS: 2US FAERS
139EczemaFAERS: 2US FAERS
140EnophthalmosFAERS: 2US FAERS
141GastritisFAERS: 2US FAERS
142GastroenteritisFAERS: 2US FAERS
143Hemisensory NeglectFAERS: 2US FAERS
144HyperreflexiaFAERS: 2US FAERS
145HyperventilationFAERS: 2US FAERS
146Incorrect dose administeredFAERS: 2US FAERS
147Incorrect route of drug administrationFAERS: 2US FAERS
148InfectionFAERS: 2US FAERS
149InflammationFAERS: 2US FAERS
150LymphadenitisFAERS: 2US FAERS
151MalnutritionFAERS: 2US FAERS
152Mazzotti reactionFAERS: 2US FAERS
153Medication ErrorFAERS: 2US FAERS
154Mental impairmentFAERS: 2US FAERS
155MydriasisFAERS: 2US FAERS
156OliguriaFAERS: 2US FAERS
157ParaplegiaFAERS: 2US FAERS
158Physical disabilityFAERS: 2US FAERS
159PregnancyFAERS: 2US FAERS
160Product prescribing errorFAERS: 2US FAERS
161Productive CoughFAERS: 2US FAERS
162ProteinuriaFAERS: 2US FAERS
163Psychotic disorder due to a general medical conditionFAERS: 2US FAERS
164Pulmonary EmbolismFAERS: 2US FAERS
165PurpuraFAERS: 2US FAERS
166Stevens-Johnson SyndromeFAERS: 2US FAERS
167Superinfection bacterialFAERS: 2US FAERS
168Therapeutic response unexpectedFAERS: 2US FAERS
169ThirstFAERS: 2US FAERS
170Unresponsive to stimuliFAERS: 2US FAERS
171Urinary tract infectionFAERS: 2US FAERS
172treatment failureFAERS: 2US FAERS
173Accidental exposure to productFAERS: 1US FAERS
174AcneFAERS: 1US FAERS
175AnxietyFAERS: 1US FAERS
176Application site swellingFAERS: 1US FAERS
177Arthropod biteFAERS: 1US FAERS
178Autoimmune hepatitisFAERS: 1US FAERS
179Back disorderFAERS: 1US FAERS
180Bacterial culture positiveFAERS: 1US FAERS
181Blood alkaline phosphatase increasedFAERS: 1US FAERS
182Blood glucose increasedFAERS: 1US FAERS
183Blood immunoglobulin G increasedFAERS: 1US FAERS
184Blood urine presentFAERS: 1US FAERS
185Body height abnormalFAERS: 1US FAERS
186Bone density abnormalFAERS: 1US FAERS
187Bone painFAERS: 1US FAERS
188Breath HoldingFAERS: 1US FAERS
189Brief psychotic disorder with marked stressorsFAERS: 1US FAERS
190BronchopneumoniaFAERS: 1US FAERS
191CachexiaFAERS: 1US FAERS
192Cardiac ArrestFAERS: 1US FAERS
193CellulitisFAERS: 1US FAERS
194Chest discomfortFAERS: 1US FAERS
195CholestasisFAERS: 1US FAERS
196ChromaturiaFAERS: 1US FAERS
197Complication associated with deviceFAERS: 1US FAERS
198ConjunctivitisFAERS: 1US FAERS
199CryingFAERS: 1US FAERS
200Delusional disorder, unspecified typeFAERS: 1US FAERS
201Device related infectionFAERS: 1US FAERS
202DiplopiaFAERS: 1US FAERS
203Disease ProgressionFAERS: 1US FAERS
204Drug toxicityFAERS: 1US FAERS
205DysphasiaFAERS: 1US FAERS
206EncephalitisFAERS: 1US FAERS
207EnteritisFAERS: 1US FAERS
208Epigastric discomfortFAERS: 1US FAERS
209EpistaxisFAERS: 1US FAERS
210ErythemaFAERS: 1US FAERS
211Exposure via eye contactFAERS: 1US FAERS
212Eye RednessFAERS: 1US FAERS
213Eye irritationFAERS: 1US FAERS
214Facial asymmetryFAERS: 1US FAERS
215Flat affectFAERS: 1US FAERS
216FlatulenceFAERS: 1US FAERS
217Foreign body sensation in eyesFAERS: 1US FAERS
218Functional residual capacity abnormalFAERS: 1US FAERS
219Gastric ulcerFAERS: 1US FAERS
220GingivitisFAERS: 1US FAERS
221Heart sounds abnormalFAERS: 1US FAERS
222Hepatic necrosisFAERS: 1US FAERS
223HepatosplenomegalyFAERS: 1US FAERS
224HepatotoxicityFAERS: 1US FAERS
225HydrocephalusFAERS: 1US FAERS
226HyperplasiaFAERS: 1US FAERS
227HyperpyrexiaFAERS: 1US FAERS
228HypokinesiaFAERS: 1US FAERS
229HyporeflexiaFAERS: 1US FAERS
230IleusFAERS: 1US FAERS
231Incorrect drug administration durationFAERS: 1US FAERS
232Incorrect product storageFAERS: 1US FAERS
233InfestationFAERS: 1US FAERS
234InfluenzaFAERS: 1US FAERS
235Injection site painFAERS: 1US FAERS
236Intention tremorFAERS: 1US FAERS
237Intentional drug misuseFAERS: 1US FAERS
238Joint swellingFAERS: 1US FAERS
239Kernig's signFAERS: 1US FAERS
240LeukocytosisFAERS: 1US FAERS
241Limb operationFAERS: 1US FAERS
242Lipase increasedFAERS: 1US FAERS
243Lower respiratory tract infectionFAERS: 1US FAERS
244MalabsorptionFAERS: 1US FAERS
245MarasmusFAERS: 1US FAERS
246Maternal exposure before pregnancyFAERS: 1US FAERS
247Maternal exposure during pregnancyFAERS: 1US FAERS
248Mechanical ventilationFAERS: 1US FAERS
249Memory impairmentFAERS: 1US FAERS
250MeningismFAERS: 1US FAERS
251MetrorrhagiaFAERS: 1US FAERS
252MoaningFAERS: 1US FAERS
253Multiple SclerosisFAERS: 1US FAERS
254Muscle tightnessFAERS: 1US FAERS
255Myocardial InfarctionFAERS: 1US FAERS
256NervousnessFAERS: 1US FAERS
257NeuropathyFAERS: 1US FAERS
258No adverse effectFAERS: 1US FAERS
259NoduleFAERS: 1US FAERS
260Oral dischargeFAERS: 1US FAERS
261Oropharyngeal painFAERS: 1US FAERS
262Pain of skinFAERS: 1US FAERS
263PancreatitisFAERS: 1US FAERS
264PanophthalmitisFAERS: 1US FAERS
265Peripheral nerve palsyFAERS: 1US FAERS
266PetechiaeFAERS: 1US FAERS
267Physical assaultFAERS: 1US FAERS
268Pneumocystis jiroveci pneumoniaFAERS: 1US FAERS
269PolyuriaFAERS: 1US FAERS
270Poor personal hygieneFAERS: 1US FAERS
271Post procedural complicationFAERS: 1US FAERS
272Product availability issueFAERS: 1US FAERS
273Product blister packaging issueFAERS: 1US FAERS
274Product dose omissionFAERS: 1US FAERS
275Product quality issueFAERS: 1US FAERS
276Punctate keratitisFAERS: 1US FAERS
277PyomyositisFAERS: 1US FAERS
278PyuriaFAERS: 1US FAERS
279Rectal tenesmusFAERS: 1US FAERS
280Relapsing FeverFAERS: 1US FAERS
281Respiratory distressFAERS: 1US FAERS
282Retrograde amnesiaFAERS: 1US FAERS
283SchistosomiasisFAERS: 1US FAERS
284Skin ErosionFAERS: 1US FAERS
285Skin UlcerFAERS: 1US FAERS
286Skin irritationFAERS: 1US FAERS
287Skin lesionFAERS: 1US FAERS
288Skinfold measurementFAERS: 1US FAERS
289SluggishnessFAERS: 1US FAERS
290Sudden deathFAERS: 1US FAERS
291Suicide attemptFAERS: 1US FAERS
292TalipesFAERS: 1US FAERS
293Temperature intoleranceFAERS: 1US FAERS
294Therapeutic product ineffective for unapproved indicationFAERS: 1US FAERS
295Therapeutic response delayedFAERS: 1US FAERS
296Therapy non-responderFAERS: 1US FAERS
297TinnitusFAERS: 1US FAERS
298TuberculosisFAERS: 1US FAERS
299Unevaluable eventFAERS: 1US FAERS
300Ventricular hypertrophyFAERS: 1US FAERS
301Vocal Cord ParalysisFAERS: 1US FAERS
302WheezingFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.